← ANALYST RATINGS · TIPRANKS
Cognizant (CTSH): analyst forecast and price target
Analyst consensus
Hold1 Buy7 Hold0 Sell
Ratings of 8 analysts in the last 3 months · top analysts only12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $60.86, the highest $70.00, the lowest $47.00. The average is −7.8% from the last price of $66.03.
Analyst ratings 23
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Information Technology ServicesxAI Grok-4 | TipRanks - xAI | $75.00 → $76.00+1.3% | Buy | +15.1% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI Anthropic Information Technology ServicesAnthropic Opus-4.6 | TipRanks - Anthropic | $72.00 → $73.00+1.4% | Buy | +10.6% | Upgrade | 17.10.26on TipRanks 13:05 | — | |
| AI Google Information Technology ServicesGemini 3.1Pro | TipRanks - Google | $75.00 → $76.00+1.3% | Buy | +15.1% | Reiterated | 17.10.26on TipRanks 13:05 | — | |
| AI DeepSeek Information Technology ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $65.00 → $73.00+12.3% | Buy | +10.6% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI OpenAI Information Technology ServicesOpenAI 5.2 | TipRanks - OpenAI | $65.00 → $74.00+13.8% | Buy | +12.1% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| AI PerPlexity Information Technology ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $67.00 → $76.00+13.4% | Buy | +15.1% | Reiterated | 16.10.26on TipRanks 08:05 | — | |
| Bryan Bergin★★★★★★★★★★#11660 · hits 43% · avg −3.3% | TD Cowen | $54.00 → $60.00+11.1% | Hold | −9.1% | Reiterated | 13.10.26on TipRanks 09:05 | +2.8%next day +2.9% | ↗ |
| Steven Wahrhaftig★★★★★★★★★★#11208 · hits 25% · avg −12.8% | Wedbush | $70.00 | Buy | +6.0% | Reiterated | 09.10.26on TipRanks 08:25 | −1.9%next day +0.9% · 5 days +13.5% | ↗ |
| Jason Kupferberg★★★★★★★★★★#12264 · hits 47% · avg −7.5% | Wells Fargo | $39.00 → $103+164.1% | Buy | +56.0% | Reiterated | 24.09.26on TipRanks 05:35 | −3.2%next day −0.3% · 5 days +6.9% | ↗ |
| Maggie Nolan★★★★★★★★★★#11936 · hits 42% · avg −7.7% | William Blair | — | Buy | — | Reiterated | 21.09.26on TipRanks 16:45 | −1.2%next day +1.5% · 5 days −1.9% | ↗ |
| Nate Svensson★★★★★★★★★★#11065 · hits 42% · avg −7.0% | Deutsche Bank | $65.00 → $70.00+7.7% | Buy | +6.0% | Assigned | 18.09.26on TipRanks 09:20 | −3.4%next day −2.4% · 5 days −5.5% | ↗ |
| Arvind Ramnani★★★★★★★★★★#11277 · hits 46% · avg −2.4% | Truist Financial | — | Hold | — | Reiterated | 16.09.26on TipRanks 07:45 | −1.8%next day −1.1% · 5 days −6.5% | ↗ |
| Darrin Peller★★★★★★★★★★#767 · hits 62% · avg +9.0% | Wolfe Research | — | Hold | — | Reiterated | 25.08.26on TipRanks 07:26 | +1.1%next day −1.6% · 5 days +1.1% | ↗ |
| Sean Kennedy★★★★★★★★★★#12112 · hits 23% · avg −20.1% | Mizuho Securities | $68.00 → $64.00−5.9% | Hold | −3.1% | Reiterated | 05.08.26on TipRanks 16:50 | +2.1%next day +0.8% · 5 days +3.0% | ↗ |
| Jonathan Lee CFA★★★★★★★★★★#12292 · hits 10% · avg −36.0% | Guggenheim | $65.00 | Buy | −1.6% | Reiterated | 05.08.26on TipRanks 08:01 | −0.4%next day +2.1% · 5 days +4.0% | ↗ |
| James Friedman★★★★★★★★★★#5808 · hits 52% · avg +0.9% | Susquehanna | $88.00 → $82.00−6.8% | Buy | +24.2% | Reiterated | 30.07.26on TipRanks 09:30 | −5.4%next day +2.0% · 5 days +1.9% | ↗ |
| Tien Tsin Huang★★★★★★★★★★#2566 · hits 54% · avg +3.8% | J.P. Morgan | $55.00 → $67.00+21.8% | Buy | +1.5% | Assigned | 30.07.26on TipRanks 09:25 | −5.4%next day +2.0% · 5 days +1.9% | ↗ |
| David Koning★★★★★★★★★★#465 · hits 57% · avg +14.0% | Robert W. Baird | $55.00 → $68.00+23.6% | Hold | +3.0% | Reiterated | 30.07.26on TipRanks 09:10 | −5.4%next day +2.0% · 5 days +1.9% | ↗ |
| Keith Bachman★★★★★★★★★★#1304 · hits 53% · avg +8.0% | BMO Capital | $50.00 → $63.00+26.0% | Hold | −4.6% | Reiterated | 30.07.26on TipRanks 07:55 | −5.4%next day +2.0% · 5 days +1.9% | ↗ |
| Bryan Keane★★★★★★★★★★#1581 · hits 59% · avg +6.7% | Citi | $45.00 → $60.00+33.3% | Hold | −9.1% | Reiterated | 30.07.26on TipRanks 06:56 | −5.4%next day +2.0% · 5 days +1.9% | ↗ |
| James Faucette★★★★★★★★★★#2607 · hits 60% · avg +3.1% | Morgan Stanley | $44.00 → $51.00+15.9% | Hold | −22.8% | Reiterated | 30.07.26on TipRanks 06:50 | −5.4%next day +2.0% · 5 days +1.9% | ↗ |
| James Schneider★★★★★★★★★★#315 · hits 63% · avg +27.5% | Goldman Sachs | $75.00 → $70.00−6.7% | Hold | +6.0% | Reiterated | 29.07.26on TipRanks Jul 30 08:31 | +12.8%next day −5.4% · 5 days −5.9% | ↗ |
| David Paige★★★★★★★★★★#882 · hits 86% · avg +39.8% | RBC Capital | $47.00 | Hold | −28.8% | Reiterated | 29.07.26on TipRanks Jul 30 07:25 | +12.8%next day −5.4% · 5 days −5.9% | ↗ |
| Mayank Tandon★★★★★★★★★★#10405 · hits 42% · avg −0.9% | Needham | — | Hold | — | Reiterated | 29.07.26on TipRanks 12:14 | +12.8%next day −5.4% · 5 days −5.9% | ↗ |
| Sachin Mittal★★★★★★★★★★#252 · hits 68% · avg +20.2% | DBS | $66.00 → $53.00−19.7% | Buy | −19.7% | Reiterated | 16.07.26on TipRanks 03:40 | +3.7%next day +1.5% · 5 days −1.8% | ↗ |
| Meha Pau★★★★★★★★★★#10476 · hits 50% · avg −11.4% | Berenberg Bank | $81.00 → $59.00−27.2% | Hold | −10.6% | Downgrade | 16.06.26on TipRanks Jun 17 01:30 | +1.0%next day −3.1% · 5 days −16.8% | ↗ |
| Surinder Thind★★★★★★★★★★#5522 · hits 45% · avg +1.5% | Jefferies | $65.00 | Buy | −1.6% | Reiterated | 15.06.26on TipRanks 10:15 | −4.4%next day +1.0% · 5 days −16.9% | ↗ |
| Kevin Mcveigh★★★★★★★★★★#3009 · hits 54% · avg +4.2% | UBS | $67.00 → $64.00−4.5% | Hold | −3.1% | Assigned | 13.04.26on TipRanks 09:06 | +3.5%next day −2.0% · 5 days −3.7% | ↗ |
| Amit Daryanani★★★★★★★★★★#21 · hits 70% · avg +37.0% | Evercore ISI | $100 | Buy | +51.4% | Reiterated | 04.02.26on TipRanks 13:40 | +3.5%next day +1.4% · 5 days −8.4% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Cognizant
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $65.80 at a price of $57.44 (+14.6%); now: $67.14 at $66.03 (+1.7%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 4 | 3 | 3 | 0 |
| Hold | 12 | 14 | 16 | 15 | 11 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $1.47 (from $1.42 to $1.50). Last quarter: $1.37.
Sales
Next quarter’s sales estimate — $5.6B (from $5.6B to $5.7B). Last quarter: $5.5B.
Best top-analyst consensus in the sector · Technology
About Cognizant
- CEO: Ravi Kumar Singisetti
- Employees: 356,700
- 300 Frank West Burr Boulevard, Teaneck, NJ, 07666, US
- www.cognizant.com
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New
Data from the stock’s TipRanks forecast page, read 47 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗